30.01.2019 // Category:
Anders Hedegaard joins the Rodenstock Group as new Chief Executive Officer
Munich 30 January 2019 – The Rodenstock Group, a global leader in eye health innovation and manufacturer of ophthalmic lenses and frames, is conducting a change in the management board.
Anders Hedegaard has been appointed as new Chief Executive Officer, effective February 1st. He follows Oliver Kastalio who has successfully led the company since 2010 and who will take on a new professional challenge.
Anders Hedegaard joins from the GN Store Nord A/S in Denmark where he was CEO of GN Hearing, an innovation leader creating best-in-class hearing aid technologies. Anders comes with a broad background in the global life science and health care sector. “I’m delighted to join Rodenstock as CEO. The company has a long tradition and strong reputation. It manufactures and distributes world-class products, utilizing most innovative technologies and has a huge growth potential”, comments Anders Hedegaard.
The Rodenstock Group just accomplished another record year with top and bottom line growth. “I have successfully managed Rodenstock’s turnaround over the past years and set the course for further growth in the eye health sector through the introduction of leading technologies like DNEye®. Now is the time to hand over management with a clear conscience," confirms Oliver Kastalio.
Rodenstock is a global leader in eye health innovation and manufacturer of ophthalmic lenses and frames. The company, which was founded in 1877 with its headquarters in Munich, employs around 4,900 people worldwide and is represented with sales offices and distribution partners in more than 85 countries. Rodenstock maintains production plants at 15 locations in 13 countries.
Kilian Manninger, VP Global Marketing
E-Mail: firstname.lastname@example.org, Phone: +49 89 7202120
For more information, visit www.rodenstock.de/presse.